HLA compatibility can be predicted by matching only three residues with outward oriented sidechains

Area of Science:

• Immunogenetics
• Transplantation immunology
• Molecular biology

Background:

• Histocompatibility matching is crucial for organ transplant success.
• Human Leukocyte Antigen (HLA) molecules play a key role in immune responses and graft rejection.
• Current matching strategies may not fully capture all critical immunogenic differences.

Purpose of the Study:

• To introduce and evaluate a new residue matching method for HLA molecules in kidney transplantation.
• To assess the impact of specific HLA residue mismatches on long-term graft survival.
• To project the potential benefits of using this residue matching method in organ allocation.

Main Methods:

• Development of a residue matching method focusing on three polymorphic, upward-oriented amino acid residues on HLA alpha-helices.
• Analysis of 10-year graft outcomes for 1232 kidney transplants.
• Comparison of outcomes between transplants with zero mismatches of the identified residues and those with zero BDR-mismatches.
• Modeling the projected impact of local allocation based on the three-residue matching system.

Main Results:

• Kidney transplants with no mismatches at the three identified HLA residues showed a projected 10-year graft survival of 47%.
• This outcome was comparable to that of transplants with zero BDR-mismatched kidneys.
• Allocation to recipients within a local pool using the three-residue matching system projected a 5% improvement in overall 10-year graft survival.

Conclusions:

• The described three-residue matching method for HLA molecules is a viable approach for assessing kidney transplant compatibility.
• This method does not appear to compromise short-term or long-term graft survival compared to existing standards.
• Implementing this residue matching strategy in organ allocation could potentially enhance overall kidney graft survival rates.